Safety and Efficacy Study of Regulatory T Cell Therapy in Liver Transplant Patients
NCT02166177
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
9
Enrollment
OTHER
Sponsor class
Conditions
End-stage Liver Disease
Interventions
DRUG:
Autologous regulatory T cell product
Sponsor
Guy's and St Thomas' NHS Foundation Trust
Collaborators
[object Object]